Co-diagnostics, inc. to present and host booth at tri-con in san diego, ca, march 6-8

Salt lake city , march 2, 2023 /prnewswire/ -- co-diagnostics, inc. (nasdaq: codx) (the "company" or "co-dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that it will be hosting a booth at the 30th molecular and precision med tri-con ("tri-con"), held virtually and in person march 6-8, 2023, in san diego, ca. co-dx, which is also one of two premier sponsors of the event, will also be delivering the lunch presentation on monday, march 6 at 11:55 am, focusing on its upcoming at-home/poct co-dx pcr home™ platform for which the initiation of clinical evaluations was recently announced.
CODX Ratings Summary
CODX Quant Ranking